TrialBone marrow transplantation2003
High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast cancer.
U De Giorgi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it